Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000037/S065

On-X Prosthetic Heart Valves and Ascending Aortic Prothesis

On-X Life Technologies, Inc. · Decision date Oct 22, 2025

FDA DECISIONP000037/S065

What did the FDA decide?

FDA records P000037/S065 as a supplement to PMA P000037, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 22, 2025.

FDA approval order statement

reducing the environmental monitoring program within the Controlled Environment Areas (CEAs)
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 22, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P000037/S065
Regulatory pathway
PMA supplement
Product code
LWQ
Decision code
OK30
Decision date
Oct 22, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: HEART-VALVE, MECHANICAL.

Product code
LWQ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P000037/S065 received

    Application receipt date recorded by FDA.

  2. P000037/S063 · Related supplement

    On-X Heart Valve; On-X Ascending Aortic Prosthesis

  3. P000037/S064 · Related supplement

    On-X Prosthetic Heart Valves; On-X Ascending Aortic Prothesis

  4. P000037/S066 · Related supplement

    On-X Prosthetic Heart Valves and Ascending Aortic Prothesis (AAP)

  5. P000037/S065 · FDA decision

    30-Day Notice

  6. P000037/S067 · Related supplement

    On-X Ascending Aortic Prosthesis

  7. P000037/S068 · Related supplement

    On-X Prosthetic Heart Valves and Ascending Aortic Prothesis

  8. P000037/S070 · Related supplement

    On-X Prosthetic Heart Valves and Ascending Aortic Prothesis

  9. P000037/S071 · Related supplement

    On-X Prosthetic Heart Valves and Ascending Aortic Prothesis (On-X AAP)

Timeline entries are records held by MedtechLedger for P000037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000037

Explore the linked device profile

Other records with product code LWQ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

On-X Life Technologies, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1655 Roberts Blvd. NW, Kennesaw, GA, 30144

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records